
==== Front
Int J Biol Sci
Int J Biol Sci
ijbs
International Journal of Biological Sciences
1449-2288
Ivyspring International Publisher Sydney

10.7150/ijbs.90798
ijbsv20p4838
Review
Potential Roles and Mechanisms of Curcumin and its Derivatives in the Regulation of Ferroptosis
Zhang Yuan 1
Yu Chenghao 1
Peng Cheng 1✉
Peng Fu 2✉
1 State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
2 Department of Pharmacology, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
✉ Corresponding author: E-mail address: pengcheng@cdutcm.edu.cn (P. C); pengf@scu.edu.cn (P. F).
Competing Interests: The authors have declared that no competing interest exists.

2024
9 9 2024
20 12 48384852
6 10 2023
25 8 2024
© The author(s)
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Ferroptosis is a recently discovered iron-dependent mode of oxidatively regulated cell death. It is not only associated with a wide range of diseases, but it is also a key component of many signaling pathways. In general, ferroptosis is a double-edged sword. On one hand, it induces nonapoptotic destruction of cancer cells, but on the other, it may lead to organ damage. Therefore, ferroptosis can be drug-targeted as a novel means of therapy. The properties of curcumin have been known for many years. It has a positive impact on the treatment of diseases such as cancer and inflammation. In this review, we focus on the regulation of ferroptosis by curcumin and its derivatives and review the main mechanisms by which curcumin affects ferroptosis. In conclusion, curcumin is a ferroptosis inducer with excellent anticancer efficacy, although it also exhibits organ protective and reparative effects by acting as a ferroptosis inhibitor. The differential regulation of ferroptosis by curcumin may be related to dose and cell type.

Curcumin
Ferroptosis
Iron
Oxidation
Anticancer effect
Organ protective effect
==== Body
pmc1. Introduction

Natural ingredients extracted from traditional Chinese medicine (TCM) are immeasurable and have been used clinically for the treatment of various diseases1,2. Curcumin is among these molecules. Historically, curcumin was isolated in 1815 by Vogel and Pelletier and was derived from the root tuber and the rhizome of Curcuma longa L.3. This herb has traditionally been known to improve blood circulation, eliminate blood stasis, and relieve pain, an effect also attributed to the presence of its phenolic constituent curcumin4. Modern studies have shown that curcumin has a wide range of pharmacological activities, such as antioxidant, antitumor, anti-inflammatory, and antiviral properties and has shown promising therapeutic potential in preclinical and clinical studies5-7. Moreover, curcumin is being "Generally Recognized as Safe" by the US Food and Drug Administration (FDA)8. Chemically, curcumin is insoluble in water and is soluble in organic solvents such as acetic acid, ketone, alkali and chloroform. Due to its hydrophobicity, instability, rapid metabolism in vivo, and poor intestinal absorption9,10, curcumin has inherent drawbacks, such as its low bioavailability, poor pharmacokinetic/pharmacodynamic properties, and poor efficacy in certain disease models11-13. Several efforts have been made to improve these properties. First, it is worthwhile to combine curcumin with photodynamic therapy. Recent findings have indicated that curcumin combined with photodynamic therapy prolonged the action time and increased the bioavailability of curcumin, resulting in a more efficient effect on cancer with a broad spectrum of targets3. Second, curcumin encapsulation using special polymers, such as liposomes and nanomaterials, has the advantages of high drug loading, high encapsulation rate, and high safety to improve curcumin bioavailability14-16. Furthermore, synthesized derivatives that are structurally similar to curcumin can be targeted to overcome these limitations and achieve good therapeutic prospects17. The chemical structures and other chemical information of curcumin and some of its derivatives are summarized in Fig. 1 and Table 1. The sources and biological activities of curcumin are displayed in Fig. 2.

Dixon first introduced the concept of ferroptosis, a new modality of cell death, to the world in 201218. Since then, research on ferroptosis has been growing exponentially over the past few years. Unlike apoptosis, autophagy, and necroptosis, ferroptosis is a distinctive programmed cell death mechanism19, as well as a new type of oxidatively regulated cell death driven by iron-dependent lipid peroxidation20,21. Specifically, when intracellular levels of lipid reactive oxygen species (L-ROS) exceed the antioxidant activity of glutathione peroxidase 4 (GPX4), this leads to a breakdown of cellular redox homeostasis22. Interestingly, ferroptosis appears to be more of a cellular "sabotage" than an active "suicide"23. In other words, ferroptosis refers to an iron-dependent, oxidative form of non-apoptotic cell death. Unlike apoptosis or autophagy, which appears to occur as a consequence of specialized molecular events taken on the initiative of cells for altruistic benefit, ferroptosis can be triggered by the depletion of the amino acid cysteine or the inhibition of GPX4, which is associated with the consumption of ATP or the production of lipid hydroperoxides with cell destruction, leading to catastrophic damage24. Mitochondria are the main intracellular generators of reactive oxygen species (ROS)25, and the focal point of iron metabolism and homeostasis26. Ferroptotic cells show characteristic morphological changes including reduction in mitochondrial volume, decrease or even disappearance of mitochondrial crista, increase in the density of the mitochondrial membrane, and rupture of outer mitochondrial membranes27,28.

Ferroptosis can be triggered by a variety of physiological conditions and pathological stresses in humans and animals and is increasingly recognized as an adaptive feature for the elimination of malignant cells18. Experimental compounds or drugs are capable of inhibiting ferroptosis in both cancer cells and certain normal cells29-31. Meanwhile, activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, up-regulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate resistant formate play key roles in the induction of ferroptosis32. Surprisingly, treatment-resistant cancer cells, especially those in a mesenchymal state and prone to metastasis, are highly susceptible to ferroptosis33. It is critical for suppressing tumorigenesis by removing cells that are deficient in key nutrients in the environment or damaged by infection or environmental stress34. In addition, many organ injuries and degenerative diseases are driven by ferroptosis35-37. Thus, pharmacological modulation of ferroptosis, through its induction and inhibition, has great potential in the treatment of drug-resistant cancers, ischemic organ damage, and other degenerative diseases associated with lipid peroxidation.

The key to ferroptosis is the iron-catalyzed peroxidation of polyunsaturated fatty acid (PUFA)-containing phospholipids (PUFA-PLs), which exceeds the buffering capacity of the defense system and ultimately leads to cell death. Accumulated intracellular iron is the trigger for ferroptosis as it can produce highly reactive free radicals via the Fenton reaction, which can lead to ferroptosis38. It has been shown that elevated intracellular ROS due to oxidative stress can accelerate the onset of ferroptosis or increase cellular susceptibility to ferroptosis inducers39. Intracellular iron accumulation and oxidation are the two central biochemical events causing ferroptosis. The ability of curcumin to chelate iron and regulate oxidation predicts that curcumin may have a role in regulating ferroptosis, which was confirmed in recent studies40,41. Herein, we review these activities and analyze the possible underlying mechanisms involved, for which there has been little information to date, in the hope of informing and contributing to the screening of natural medicines.

2. Curcumin and its derivatives promoted ferroptosis in cancerous cells

2.1 Regulation of iron metabolism

Iron's role in the redox cycle where it can act as an electron carrier allows it to catalyze the Fenton reaction with H2O2, followed by the production of highly reactive hydroxyl radicals (•OH), which, as part of ROS, can damage macromolecules such as lipids, proteins, and DNA, as well as cellular organelles such as lysosomes and mitochondria, and has been linked to various signaling pathway impairments42. Iron homeostasis is tightly regulated in healthy cells to balance systemic absorption and distribution as well as cellular uptake, storage and export43,44. A distinctive hallmark of cancer is dysregulation of iron homeostasis, including overexpression of genes involved in iron metabolism and increased intracellular labile iron45,46. Of particular note, tumor cell growth and survival cannot occur without an increase in iron concentration, and an increase in intracellular labile iron pools is also essential for cancer cell metastasis. However, increased iron levels can also lead to ferroptosis via the Fenton reaction38. Cancer management is becoming as diverse as the disease itself. Targeting iron metabolism in cancer cells is a powerful and promising therapeutic area.

Cellular iron metabolism involves the regulation of labile iron in the cell membrane, which is a minor but vital part of the total amount of redox-active iron in the cell19. Convincing evidence has shown that curcumin and its derivatives can induce iron accumulation by increasing the concentration of Fe2+ in a wide range of tumor cells and tissues47-51. Furthermore, Yin et al. developed a cascade catalytic nanoplatform (CaO2/Tf /CUR) for ion interference therapy. CaO2/Tf/CUR with tumor-targeting action was internalized in tumor cells and decomposed to release Ca2+ and curcumin. CaO2/Tf/CUR activated the mitochondrial apoptotic signaling pathway by inducing Ca2+ overload which further led to cellular damage. Conversely, the generated H2O2 disrupted the structure of transferrin (TF) thus releasing Fe3+. Ferroptosis is triggered by conversion to hydroxyl radicals via trivalent iron ion-mediated Fenton reaction52. DMT1 acts as a proton pump and utilizes the cell membrane potential for active iron transport. Ling et al. found that HO-3867 was able to upregulate DMT1 expression by regulating the level of p5351.

Iron uptake through the transferrin receptor 1 (TFR1) and storage in ferritin (FT) is vital for regulating the labile iron pool in the cytoplasm. Among the many factors that affect iron metabolism, FT has been investigated to understand the mechanisms of release/accumulation of reactive iron as an important regulatory point for iron metabolism homeostasis and ferroptosis53. Activation of iron metabolism-related proteins promotes ferroptosis54. However, another argument suggests that the regulation of labile iron by overexpression of FT decreases the production of reactive free radicals, whereas the down-regulation of FT increases oxidative damage55. Curcumin has been proven to modulate TFR1 levels, as well as the two subunits of FT, in cancer cells, ferritin heavy chain (FTH1) and ferritin light chain (FTL), which in turn influences intracellular iron transport and storage functions and alters labile iron levels50,56-58. The suppression of IREB2, a prominent transcription factor involved in the regulation of iron metabolism, resulted in a notable increase in the expression of FTL and FTH1, consequently preventing the occurrence of erastin-induced ferroptosis59. Meanwhile, siIREB2 interference could reduce curcumin-induced cell death in A549 and H1299 cells, indirectly indicating that curcumin could participate in the ferroptosis process in lung cancer cells by targeting IREB2. Furthermore, curcumin can down-regulate the level of NCOA4 in clear cell renal cell carcinoma by upregulating the ADAMTS18 gene, which contributes to cell death and reverses resistance to sunitinib. This is because the delivery of FT to lysosomes requires NCOA4, which is highly aggregated in autophagosomes. In other words, cells lacking NCOA4 do not degrade FT, leading to a decrease in bioavailable intracellular iron60.

The enzyme known as heme oxygenase-1 (HO-1) converts heme into free iron, carbon monoxide, and bilirubin. Under typical physiological circumstances, HO-1 scavenges ROS and offers cellular defense61. Yet, curcumin-induced HO-1 overactivation raises intracellular ferric ions, MDA, and ROS levels in cancer cells, surpassing FT's buffering ability and leading to the uncontrollably high release of iron and the consequent disturbance of iron metabolism48,56,58,62,63. Remarkably, while inhibiting the expression of GPX4, curcumin not only directly activates HO-1, but also upregulates its expression by activating Nrf2, promoting ferroptosis56.

2.2 Inhibition of the antioxidant system

Organisms have developed a variety of antioxidant regulators, such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX), as a means to protect against oxidative damage64. However, when these defense mechanisms are disrupted, resulting in an imbalance between the production and removal of ROS, cells experience impaired functionality or even death due to oxidative stress65. Cancer cells exhibit intrinsic oxidative stress, which makes them more susceptible to further ROS production by pro-oxidant anticancer agents (PAAs). However, PPAs inevitably generate ROS in normal cells, resulting in a narrow therapeutic window and high toxicity, which greatly limits their clinical application66. In the tumor microenvironment (TME), tumor cells evolve to gradually be insensitive to oxidative stress or other harmful forces, leading to their resistance to stress-inducing agents such as chemotherapy and radiotherapy67. In this context, ferroptosis could be a robust tool for developing a novel strategy by amplifying oxidative stress or inhibiting antioxidant molecules in tumor cells.

2.2.1 GPX4/GSH

Ferroptosis inducers such as glutamate and erastin can drain GSH and inactivate the enzyme activity of GPX4 by blocking the import of cystine by the cystine/glutamate antiporter (system Xc-)68,69. GPX4 is an essential regulator of ferroptosis in cancer cells as well as a key factor in maintaining cellular redox homeostasis70. GSH, as an important iron inhibitor and non-enzymatic antioxidant, provides an important defense system that protects cells from different types of oxidative stress71. GPX4 converts GSH to oxidized glutathione (GSSG) and the cytotoxicity of lipid peroxides (L-OOH) to the corresponding alcohol (L-OH)72-74. The ratio between GSH and GSSG generally indicates the level of cellular oxidative stress. However, L-OOHs are unstable and can be broken down into reactive compounds such as MDA, which acts as a "second messenger of oxidative stress" due to its long half-life and its ability to diffuse out of the formation site75,76. Together, GPX4 and GSH appear to be the major determinants of the balance between cell proliferation and death. Inactivation of GPX4 or depletion of GSH in cells may lead to ferroptosis77. ALZ003-induced AR ubiquitination improves glioblastoma resistance to temozolomide by disrupting GPX4-mediated redox homeostasis and promoting subsequent ferroptosis78. Curcumin inhibits GPX4 levels by upregulating Nrf2 expression, triggering the molecular and cytological characteristics of ferroptosis in breast cancer cells56. Curcumin and its derivative EF24 repress GPX4 expression and increase MDA and ROS levels to exert a pro-ferroptosis effect in osteosarcoma cells48,79. Similarly, a notable increase in MDA content was detected in tumor tissues of non-small cell lung carcinoma mice treated with curcumin, accompanied by a decrease in SOD activity49. It is well known that SOD is an indispensable constituent of the antioxidant enzyme system in biological systems. Meanwhile, a reduction in GSH content and L-OOH levels was measured in curcumin-treated TNBC cells58. Liu et al. designed a hypoxia-responsive nanodelivery system based on angelica polysaccharides and used curcumin as a model drug. When such curcumin-loaded micelles were employed in hepatocellular carcinoma mice, ferroptosis in solid tumors could be selectively enhanced by reducing GSH under hypoxic conditions80. Zhong et al. constructed a photodynamic therapy/photothermal therapeutic system by loading curcumin onto Au NRs, taking advantage of the varying pH and ROS levels of tumors and normal tissues to promote the production of lipid peroxide in melanoma81.

2.2.2 System Xc-

System Xc- consists of two subunits, SLC7A11 and SLC3A2, and is an amino acid reverse transporter protein. Cystine and glutamate are exchanged intracellularly and extracellularly through System Xc- in a 1:1 ratio18. Absorbed cystine is reduced in the cell to cysteine, which continues to be involved in GSH synthesis and influences GPX activity. Interestingly, curcumin induced a decrease in SLC7A11 levels in tumor tissues from homozygous Lewis lung carcinoma mice, and this phenomenon was similarly observed in several lung cancer cells49,82. Furthermore, recent studies found that curcumin also negatively regulated the expression of SLC7A11 in colorectal cancer cells through PI3K/Akt/mTOR and p53 signaling, which selectively caused ferroptosis and suppressed cancer cell proliferation83,84.

2.2.3 Glutamine

Glutamine is a conditionally essential amino acid for rapidly proliferating tumor cells85. Studies have shown that aberrant glutamine metabolism can promote cellular ferroptosis by enhancing the accumulation of lipid peroxides54,86,87. curcumin facilitates glutamine consumption by upregulating the expression of solute carrier family 1 member 5 (SLC1A5), a critical glutamine transporter, and exerts its antitumor effects against breast cancer in vitro and in vivo50.

2.2.4 FSP1-CoQ10- NAD(P)H

Several studies have revealed that inhibition of GPX4 does not initiate ferroptosis in some cancer cell lines, suggesting the existence of alternative antiferroptosis regulators in cancer cells88-90. In line with this hypothesis, recent studies have confirmed the presence of the FSP1-CoQ10- NAD(P)H pathway as an independent parallel system involved in the curbing of lipid peroxidation and ferroptosis in cooperation with GPX4/GSH88. FSP1, previously known as apoptosis-inducing factor mitochondria-associated protein 2 (AIFM2), was identified as a GPX4-independent ferroptosis inhibitory protein89. As a lipophilic free radical adsorbing antioxidant, FSP1 prevents the propagation of lipid peroxides. More specifically, inositolized FSP1 is recruited to plasma membranes and uses NAD(P)H to catalyze the reduction of ubiquinone (CoQ10), forming ubiquinol as a free radical trapping antioxidant to terminate serum lipid peroxidation (LPO) and ultimately inhibit ferroptosis74. Curcumin downregulates the levels of FSP1, CoQ10, and NAD+/NADH proteins in tumor cells. Meanwhile, the positive expression of FSP1 in tumor tissues was also obviously downregulated by curcumin. Further studies revealed that an inhibitor of ferroptosis (Fer-1) significantly suppressed these curcumin-mediated effects91. Pharmacological inhibition of FSP1 synergized with inhibition of GPX4 to induce ferroptosis in many cancer cells. Thus, dual repression of GPX4 and FSP1 by curcumin is considered promising cancer therapy92.

2.2.5 Thioredoxin reductase

Thioredoxin reductase (TrxR) catalyzes the reduction of disulfide bonds in thioredoxin (Trx) with the help of NAD(P)H. Subsequently, Trx interacts with a series of downstream proteins through thiol-disulfide exchange to regulate redox signaling events and protect cells from ROS-induced oxidative damage93,94. Overall, TrxR, together with Trx and NAD(P)H, constitutes a sulfur-oxygen reduction protein system that maintains cellular redox homeostasis95. oxidative stress, cancer cells typically overexpress TrxR96, making the enzyme an attractive cancer-specific target97-99. The curcumin derivative 2c was able to selectively cause ROS-dependent apoptosis and ferroptosis in human non-small cell lung cancer cells, but not in human normal lung cells, by covalently modifying the Sec-498 residue of intracellular TrxR and generating ROS. Of interest, curcumin derivative 2c also dramatically arrested the growth of transplanted tumors in nude mice with non-small cell lung cancer cells without obvious toxicity to the liver or kidneys66.

2.3 Other mechanisms

Wang et al. validated in vivo that silencing of circFOXP1 enhanced the expression of ferroptosis markers, establishing elevated levels of circFOXP1 in tumors and supporting its potential prognostic role in lung cancer. The specific mechanism involved circFOXP1 enhancing SLC7A11 expression in cancer cells by direct sponge adsorption of miR-520a-5p. Curcumin and quercetin inhibited the expression of circFOXP1 in lung cancer cells by regulating the miR-520a-5p/SLC7A11 axis, which in turn affected cell growth, migration and invasion as well as ferroptosis47. Curcumin can induce ferroptosis in colorectal cancer cells by down-regulating JNK signaling100, as well as affecting a variety of ferroptosis-related genes101. MitoCur-1 reversed melanoma cell resistance to vemurafenib by inhibiting USP14 and promoting ferroptosis102. A growing number of findings suggest that ferroptosis frequently interferes with the immune response, leading to inflammation-associated immunosuppression103,104. During the development of alternative herbal medicines for the treatment of gastric cancer based on transcriptomic analysis of immune infiltration and ferroptosis, Li et al. discovered that TLR4 and KRAS, as common genes for immune infiltration and ferroptosis, play a major role in the progression of gastric cancer. Based on the prediction of these two key genes, several herbal components, including curcumin, provide research directions and alternative therapies for immunomodulation in the TME and ferroptosis of gastric cancer105. A recent study demonstrated that NL01 induced ferroptosis in two types of ovarian cancer cells. Intriguingly, this new derivative of curcumin was 13-times more potent than curcumin in curbing the growth of cancer cells. Further studies revealed that the mechanism by which NL01 contributes to ferroptosis is associated with lactate metabolism. It can reduce lactate uptake from the extracellular environment by decreasing the expression of hydroxycarboxylic acid receptor 1 (HCAR1)/monocarboxylic acid transporter protein 1 (MCT1), and activate the AMPK/ SREBP1 pathway to lower glucose uptake and lactate production to improve energy metabolism. Knockdown of HCAR1 expression revealed phenotypic and pathway alterations similar to those of NL01 treatment, which inversely validated the rationale for targeting lactate metabolism106.

Last but not least, curcumin also affects the expression of proteins related to endoplasmic reticulum stress and autophagy pathways in cancer cells undergoing ferroptosis56. It is reasonable to infer that endoplasmic reticulum stress and autophagy may also be involved in the modulation of ferroptosis in cancer cells by curcumin, which requires further experimental verification. The mechanism of action of curcumin and its derivatives in cancer cells is summarized in Fig. 3 and Table 2.

3. Curcumin and its derivatives inhibited ferroptosis in tissue-damaged models

3.1 Brain

Curcumin is one of the few polyphenols that exhibit dramatic protective effects against ferroptosis-induced damage to cells107. Through activation of the Nrf2/HO-1 pathway, curcumin can both restrict high glucose-induced neuronal (N2a) cell injury108 and promote clearance of intracranial hematomas, reduce perihematoma brain edema as well as promote neurological recovery after intracerebral hemorrhage (ICH)109. The main underlying mechanisms that produce this event are closely related to the antioxidant system and the iron metabolism regulatory system of curcumin. Curcumin pretreatment also effectively attenuated oxidative stress and neural ferroptosis in the ICH model by upregulating the antioxidant activity of mesenchymal stem cells (OM-MSCs)110. In addition, encapsulation of curcumin in nanoparticles (Cur-NPs) can better facilitate the delivery of curcumin to the brain through the physiological barrier111. Yoko et al. applied hybrid molecules consisting of the oxidized indole backbone of neuroprotective compounds and the polyphenol backbone of curcumin to mouse hippocampal HT22 cells for experimental purposes and noted that these preparations possessed superior neuroprotection and lower cytotoxicity compared to curcumin. In particular, they scavenge ROS to shield cells from endogenous oxidative stress as well as ferroptosis through stimulation of antioxidant-responsive elements and chelation of ferrous ions, and finally foster neuronal survival112-115.

3.2 Heart

Combining various modern techniques, Feng et al. identified the key gene TGFBR1 from the efficient screening of immunity and ferroptosis-related biomarkers and immunomodulatory ability of herbal ingredients. TGFBR1 was found to dock well with curcumin, which was further validated to substantially attenuate myocardial fibrosis for the management of valvular atrial fibrillation116. Diabetes disordered the arrangement of cardiomyocytes and significantly enlarged the degree of myocardial fibrosis and collagen expression in cardiomyocytes. Curcumin treatment increases the nuclear translocation of Nrf2 and the expression of GPX4 and HO-1, alleviates glucose-induced cardiomyocyte injury, and reverses erastin-induced ferroptosis in cardiomyocytes117. Furthermore, curcumin mitigates oxidative stress, ferroptosis, and liver, pancreas, and heart injury after myocardial ischemia-reperfusion injury by modulating cellular lipid composition118.

3.3 Liver

Curcumin can help promote the excretion of excess Cu2+ in a concentration-dependent manner, diminish the accumulation of Cu2+, reduce intracellular Cu2+ content in hepatolenticular degeneration (HLD) hepatocytes, and protect the copper-injured HLD model from oxidative stress based on the Nrf2/HO-1/GPX4 signaling pathway to achieve a protective function in normal rat hepatocytes119. Parallel to this, in liver-injured heterozygous silver crucian carp, curcumin relieved ammonia-induced oxidative stress and ferroptosis by inhibiting ROS and MDA levels along with activation of the Nrf2 pathway120.

3.4 Kidney

There is no specific treatment for kidney damage caused by rhabdomyolysis. Ferroptosis is involved in cellular wounding and inflammation induced by rhabdomyolysis in vivo and in vitro. Curcumin dampened the characteristic changes in ferroptosis, which subsequently improved renal injury and inflammation41,121. HO-1 is a key pathway involved in the protective properties of curcumin122. The hydrophobic core of ferritin nanocages can load curcumin and specifically deliver it to the site of renal injury, improving bioavailability. More importantly, curcumin and ferritin nanocages can synergize their antioxidant activities to reduce ferroptosis and invert the pathological process of ischemia-reperfusion acute kidney injury (IR-AKI) by reducing ROS and absorbing overloaded iron, respectively123.

3.5 Other properties

Curcumin improves functional and histological lung damage from cigarette smoke and eases pulmonary ferroptosis, suggesting that curcumin may play a beneficial role in patients with COPD by limiting ferroptosis124. Encapsulation of cerium oxide nanoparticles (CeO2) and curcumin in mannose-modified chitosan (MCS) enhanced the therapeutic efficacy of inflammatory bowel disease (IBD), on the one hand, by increasing the expression of GSH and GPX4 to protect intestinal cells from ferroptosis, and, on the other hand, it could leverage the targeting of macrophages to minimize effects beyond the site of colonic inflammation125. Recent studies have demonstrated this phenomenon of curcumin suppression of ferroptosis in a mouse model of periodontal tissue injury in periodontitis, in which lipid peroxidation and System Xc- are involved and exert a crucial role126. Curcumin and its derivative acetyl zingerone can ameliorate osteoarthritis (OA) via the Nrf2 pathway127,128. In testicular tissue, curcumin upregulated SP1 and PRDX6 to stimulate self-protection against damage from ferroptosis129. The efficacy of curcumin and its derivatives in tissue-damaged models is shown in Fig. 4 and Table 3.

4. Conclusions and perspectives

Curcumin and its derivatives induced death in cancer cells, and bioinformatics analyses have revealed that the ferroptosis pathway was enriched more than other cell death pathways56,105. Moreover, inhibitors of apoptosis, necrosis, and autophagy failed to counteract this death outcome48. This fully justifies the importance of ferroptosis in the process of curcumin potency. For the first time, in this review, we comprehensively summarize the connection between curcumin and ferroptosis. We found that applying curcumin to different disease types and tissues causes ferroptosis to develop differently. In cancer, curcumin, on the one hand, directly or indirectly regulates cellular iron levels and, on the other hand, disrupts the antioxidant system by modulating pathways such as GPX4/GSH, FSP1-CoQ10- NAD(P)H. In contrast, curcumin exerts its iron-chelating effects in noncancer cells and ameliorates oxidative stress, curbing damage associated with ferroptosis in the brain, heart, liver, kidney, and other systems (Fig. 5). These hints point to a complicated curcumin regulation in various cell types that has to be elucidated.

Fundamentally, a variety of elements appear to influence the results produced by curcumin and its derivatives on organisms. To begin with, the TME is a complex system with multiple levels and scales130,131. Tumor tissues are characterized by different properties than normal tissues, including slightly low pH and ROS overproduction, which lead to cancer cells with intrinsic oxidative stress, which is a key biochemical characteristic that distinguishes cancer cells from normal cells132,133. Curcumin-generated ROS become the last straw (Fig. 6). Conversely, higher levels of GSH are present in normal cells, which serves as a cellular defense system against ROS134. What's more, macrophages are capable of scavenging additional ROS produced in response to curcumin in vivo, thus preventing ferroptosis83,135. Equally important is that iron in cells is a central factor in cancer progression136. Tumor cells contain more iron than normal cells and proteins related to the regulation of iron metabolism are highly expressed in tumor tissues137. Therefore, the iron dependence of cancer cells makes them more susceptible to ferroptosis than normal cells45,138-142. Second, at the cellular level, the mechanism of action of curcumin and its derivatives is complex and multifactorial. A recent study found that HO-3867 caused downregulation of p53 in ovarian cancer cells143. However, Ling et al. presented experimental results showing that p53 levels tended to increase in NSCLC cells treated with HO-386751. These variations are most likely due to the different doses of curcumin used. Curcumin stimulates HO-1 expression at low concentrations but seems to be less effective at higher concentrations144. The hormonal effects of curcumin have also been demonstrated in several studies145-150. It is a great antioxidant at low doses and has excellent pro-oxidant activity at high doses (≥20 μM)147. This also emphasizes the importance of having a proper dosage of the drug in the hands of the clinician.

Natural products, with their wide chemical diversity, have been one of the most valuable avenues for the screening of novel clinical drugs. Izzo et al. demonstrated a new pharmacological practice guideline for the study of natural products, which could be beneficial for the reproducibility of studies on natural products151. The majority of research on curcumin presented in this review, however, does not refer to the methodology in the guidelines and suffers from a lack of standardization. In terms of the mechanisms investigated, the FSP1-CoQ10- NAD(P)H pathway is linked to the endosomal sorting complex required for transport III (ESCRT-III), as FSP1 is able to inhibit ferroptosis through a membrane repair process that involves the transportation of the ESCRT-III152. Additionally, spermidine/spermine N1-acetyltransferase 1 (SAT1) is a transcriptional target of P53, and activation of SAT1 promotes ROS-induced lipid peroxidation and ferroptosis, which is closely related to the expression of arachidonate lipoxygenase 15 (ALOX-15)153. Regrettably, no reports have described curcumin regulation of ferroptosis through modulation of the SAT1, ALOX-15, and ESCRT-III. Likewise, the epigenetic regulation of ferroptosis has been poorly studied. What are the roles of DNA methylation, RNA methylation, and post-translational modifications in the regulation of ferroptosis? How can epigenome editing be used to manipulate tumor cell sensitivity? These questions signal the need for additional pharmacological studies to explore the underlying mechanisms of ferroptosis mediated by curcumin.

Parts of the figures were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).

Funding

This work was supported by the National Natural Science Foundation of China (Nos.81891012; U19A2010), the Youth Talent Promotion Project of China Association for Science and Technology (No. CACM-2020-QNRC1-01), the National Interdisciplinary Innovation Team of Traditional Chinese Medicine (No.ZYYCXTD-D-202209), the Project of Science and Technology Department of Sichuan Province (Nos.2023NSFSC1928; 2023NSFSC1992), the Multidimensional Evaluation of Specialty Chinese Medicine Resources and Product Development Innovation Team (No.2022C001), and the Fundamental Research Funds for the central Universities.

Author contributions

Yuan Zhang: Conceptualization, Investigation, Visualization, Writing - original draft. Chenghao Yu: Conceptualization, Investigation, Visualization. Fu Peng: Conceptualization, Writing - review & editing, Supervision. Cheng Peng: Conceptualization, Writing - review & editing, Supervision.

Abbreviations

AIFM2 apoptosis-inducing factor mitochondria-associated protein 2

Akt protein kinase B

ALOX-15 arachidonate lipoxygenase 15

AMPK AMP-activated protein kinase

CAT catalase

COPD chronic obstructive pulmonary disease

CoQ10 coenzyme Q10

DMT1 recombinant divalent metal transporter 1

ECM extracellular matrix

ESCRT-III endosomal sorting complex required for transport III

FDA Food and Drug Administration

FSP1 ferroptosis suppressor protein 1

FT ferritin

FTH1 ferritin heavy chain

FTL ferritin light chain

Gox glucose oxidase

GPX glutathione peroxidase

GPX4 glutathione peroxidase 4

GSH glutathione

GSSG oxidized glutathione

HCAR1 hydroxycarboxylic acid receptor 1

HLD hepatolenticular degeneration

HO-1 heme oxygenase 1

IBD inflammatory bowel disease

ICH intracerebral hemorrhage

IR-AKI ischemia-reperfusion acute kidney injury

IREB2 iron-responsive element binding protein 2

JNK c-Jun N-terminal kinase

KRAS Kirsten rat sarcoma viral oncogene

LPO lipid peroxide

L-ROS lipid reactive oxygen species

MCT1 monocarboxylic acid transporter protein 1

MDA malondialdehyde

mTOR mechanistic target of rapamycin

NAD(P)H nicotinamide adenine dinucleotide phosphate hydrogen

NCOA4 nuclear receptor coactivator 4

Nrf2 nuclear factor-E2-related factor 2

OA Osteoarthritis

OM-MSCs mesenchymal stem cells

p53 transformation related protein 53

PAAs pro-oxidant anticancer agents

PI3K phosphatidylinositol 3-kinase

PRDX6 peroxiredoxin 6

PUFA polyunsaturated fatty acid

PUFA-PLs polyunsaturated fatty acid-containing phospholipids

REBP1 sterol regulatory element-binding protein 1

ROS reactive oxygen species

SAT1 spermidine/spermine N1-acetyltransferase 1

SLC1A5 recombinant solute carrier family 1, member 5

SLC3A2 recombinant solute carrier family 3, member 2

SLC7A11 recombinant solute carrier family 7, member 11

SOD superoxide dismutase

SP1 specific protein 1

TF transferrin

TFR1 transferrin receptor 1

TGFBR1 transforming growth factor beta receptor 1

TLR4 toll-like receptor 4

TME tumor microenvironment

Trx thioredoxin

TrxR thioredoxin reductase

USP14 ubiquitinspecific protease 14

Figure 1 The chemical structures of curcumin and some of its derivatives (drawing by InDraw).

Figure 2 The sources and biological activities of curcumin.

Figure 3 Curcumin and its derivatives exert antitumor effects by modulating the ferroptosis pathway.

Figure 4 Regulatory mechanisms of curcumin on oxidative stress. Curcumin exerts antioxidant properties by activating both Nrf2-related pathways and the antioxidant system.

Figure 5 Multifaceted roles of curcumin and its derivatives in ferroptosis as the antiferroptosis or pro-ferroptosis agent.

Figure 6 Generation and regulation of cellular ROS. Healthy cells have developed adequate adaptations to overcome the damaging effects of ROS. Balanced generation of ROS, sufficient antioxidant activity and scavenging by macrophages result in low concentrations of ROS. Tumorigenic events including oncogene activation, macrophage infiltration or hypoxia/reoxygenation processes in tissues yield high ROS concentrations. Curcumin-generated ROS become the last straw.

Table 1 The chemical information of curcumin and some of its derivatives.

Chemical name	Formula	Molecular weight (g/ mol)	Type	
Curcumin	C21H20O6	368.38	Natural polyphenol compound	
NL01	-	-	-	
HO-3867	C28H30F2N2O2	464.55	Synthesized diarylidenylpieperidone compound	
EF24	C19H16ClF2NO	347.79	Synthesized monoketone compound	
Acetyl zingerone	C13H16O4	236.26	-	
MitoCur-1	C65H64Cl2O6P2	1074.05	-	

Table 2 Curcumin and its derivatives promoted ferroptosis in cancerous cells.

Disease	Experimental model	Concentration	Major mechanism	Effects	Reference	
Glioblastoma	U87MG/A172 cells	0.5-10 μM	AR↓, GPX4↓, ROS↑	Inhibited cell survival	78	
Follicular thyroid cancer
Lung cancer	FTC-133/FTC-238 cells	1-128 μM	HO-1↑, GPX4↓, MDA↑, GSH↓, ROS↑	Inhibited tumorigenesis	62	
HT29 cells xenograft mice	-	-	Inhibited cell growth, migration and invasion	47	
Lewis cells xenograft mice	100 mg/kg	MDA↑, SOD↓, GSH↓, Fe2+↑, ACSL4↑, SLC7A11↑, GPX4↑	Inhibited tumor growth and promoted cell death	49	
A549/H1299 cells	3.1-100 μM	MDA↑, SOD↓, GSH↓, Iron↑, ACSL4↑, SLC7A11↓, GPX4↓	Inhibited cell proliferation and promoted cell death	49	
A549 CD133+ cells	0.01-0.08 μmol/ml	ROS↑, GSH↓, CoQ10↓, NAD+/NADH↓, GPX4↓, FSP1↓	Inhibited cellular self-renewal capacity	91	
A549 CD133+ cells xenograft mice	100 mg/kg	GPX4↓, FSP1↓	Inhibited tumor growth	91	
H460/PC-9/H1975/A549/H1299/A549 p53 KO/H460 p53 KO cells	5-80 μM	p53↑, DMT1↑, ROS↑, GPX4↓	Inhibited cell viability and promoted cell death	51	
NCI-H460/A549/HepG2/HT-1080 cells	0.5-2 μM	TrxR↓, ROS↑	Promoted cell death	66	
NCI-H460 cells xenograft mice	5-15 mg/kg	TrxR↓, GPX4↓	Inhibited tumor growth	66	
LK-2/H1650 cells	10-40 μM	DMRT3↓, SLC7A11↓	Inhibited cell proliferation, tumorigenesis and induced apoptosis	82	
LK-2 cells xenograft mice	50 mg/kg	Inhibited tumor growth	
Liver cancer	HepG2/HUVECs cells	-	GSH↓	Inhibited cell proliferation and promoted cell death	80	
KMCH/Huh7/PLC cells	25 μM	HO-1↑	Promoted cell death	63	
Breast cancer	MCF7/MDA-MB-231 cells	14-50 μM	Nrf2↑, HO-1↑, GPX4↓	Promoted cell death	56	
MCF-7 cells	-	-	Promoted cellular damage	52	
MDA-MB-453/
MCF-7 cells	1-50 μM	ROS↑, MDA↑, Fe2+↑, SLC1A5↑, GPX4↓, FTL↓, ACSL4↑, NOX1↑	Promoted cell death	50	
MCF-7 cells xenograft mice	30 mg/kg	MDA↑, Fe2+↑, SLC1A5↑, GSH↓	Inhibited tumorigenesis	50	
MCF-7/MDA-MB-231 cells	5-50 μM	HO-1↑, GPX4↓, FHC↑, Fe2+↑, LOOH↑	Inhibited cell viability	58	
Gastric cancer	-	-	TLR4, KRAS	-	105	
Colorectal cancer	HCT-8 cells	1-100 μM	Iron↑, MDA↑, ROS↑, GSH↓, GPX4↓, SLC7A11↓, p-PI3K↓, p-Akt↓, p-mTOR↓	Inhibited cell proliferation	83	
SW480/HCT116 cells	1-5 μg/ml	GPX4↓, FSP-1↓	Inhibited cell proliferation, clone formation and induced apoptosis	92	
SW620/LoVo cells	10-80 μM	p53↑, GPX4↓, SLC7A11↓	Inhibited cell proliferation, migration and clone formation	84	
SW620 cells xenograft mice	100 mg/kg	Inhibited tumor proliferation	
SW480 cells	0-100 μM	JNK↓	Inhibited cell proliferation	100	
SW480 cells	5-50 μM	-	Inhibited cell proliferation	101	
Clear cell renal cell cancer	A498/786-O cells	2-10 μM	ADAMTS18↑, NCOA4↓, FTH1↓, p53↓	Inhibited cell proliferation	57	
Ovarian cancer	Anglne/HO8910PM cells	1-8 μM	HCAR1↓, MCT1↓	Inhibited cell growth	106	
HO8910PM cells xenograft mice	5 mg/kg	Inhibited tumor proliferation	106	
Osteosarcoma	U2os/Saos-2 cells	0.5-4 μM	HO-1↑, GPX4↓, MDA↑, ROS↑, Iron↑	Inhibited cell viability and promoted cell death	48	
MNNG/HOS/MG-63 cells	-	Nrf2↓, GPX4↓	Inhibited cell proliferation and invasion, induced apoptosis and G0/G1 phase arrest	79	
MNNG/HOS xenograft mice	-	Inhibited tumor proliferation	
Melanoma	A375/B16 cells	-	LPO↑	Promoted cell death	81	
A375/SKMEL28 cells	1-4 μM	USP14↓, GPX4↓, SLC7A11↓, GSH↓	Inhibited cell proliferation and migration, induced apoptosis and cell cycle arrest	102	

Table 3 Curcumin and its derivatives inhibited ferroptosis in tissue-damaged models.

Disease	Experimental model	Concent-ration	Major mechanism	Effects	Reference	
Diabetic neuropathy	N2a cells	0.005 μmol/ ml	Fe2+↓, GPX4↑, SLC7A11↑, FTH1↑, TFR-1↓, Nrf2↑, HO-1↑	Inhibited nerve cell death and promoted nerve cell viability	108	
Intracerebral hemorrhage	ICH rats	0.001-100 μM	Nrf2↑, HO-1↑	Promoted the clearance of intracranial hematoma, reduced perihematomal brain edema, and promoted the recovery of neurological functions	109	
Neurons	10 μM	Fe2+↓, Iron↓, GPX4↑, FTH1↑, SLC7A11↑, ACSL4↓	Reduced cell damage and nerve death	110	
ICH rats	-	Reduced blood-brain barrier dysfunction in brain tissue surrounding hematoma	110	
HT22 cells	2.5-320 μM	ROS↓, Nrf2↑, HO-1↑	Inhibited hippocampal cell death	111	
Neurodegenerative disorders	HT22 cells	10-50 μM	ARE↑, HO-1↑	Protected nerves	112	
10-25 μM	GCLC↑, Sp1↑	Promoted neuronal survival	113	
0.1-10 μM	ROS↓, Fe2+↓	Inhibitd oxidative apoptosis and protected dopaminergic neurons	114	
0.1-10 μM	ROS↓	Inhibited hippocampal cell death	115	
Valvular atrial fibrillation	HL-1 cells	0.005-1 μmol/ ml	TGFBR1↓	Reduced myocardial fibrosis	116	
Dabetic cardiomyopat-hy	Diabetic rabbits	300 mg/kg	-	Improved myocardial structure	117	
H9C2 cells	0.001-0.018 μmol/ ml	Nrf2↑, HO-1↑, GPX4↑	Alleviated the injury of cardiac myocytes and reversed the death of cardiac myocytes	117	
Ischemia/repe-rfusion injury	Ischemia/repe-rfusion-damaged rats	100 mg/kg	ACSL↓, GPX4↑	Reduced damage to the heart, liver and pancreas	118	
Hepatolenticul-ar degeneration	TX mice	50-100 mg/kg	-	Inhibited liver damage	119	
BRL-3A cellls	2.5-10 μM	Nrf2↑, HO-1↑, GPX4↑		
Liver injury	Gibel carp with liver injury	-	ROS↓, MDA↓, Nrf2↑, ACSL4↓, PTGS2↓, SLC7A11↑	Improved mitochondrial morphology	120	
Acute kidney injury	Mice with rhabdomyolys-is	1000 mg/kg	HO-1↑, MDA↓, GSH↑	Improved the function and histology of renal damage	122	
MCTs/HK-2 cells	10 μM		
HK-2 cells	1-40 μg/ml	ROS↓, Iron↓	Improved renal function and reversed the pathological process of IR-AKI	123	
Human renal tubular epithelial cells	5-40 μM	p62↑, Keap1↑, Nrf2↑	Promoted cell proliferation	121	
Mice with kidney injury	50 mg/kg	Reduce the histopathological lesions in the kidney	
	Ducks with kidney injury	400 mg/kg	NCOA4↓	Alleviated growth retardation and renal distorted structure	41	
COPD	BEAS-2B cells	5-20 μM	MDA↓, Iron↓, ROS↓, GSH↑, SLC7A11↑, GPX4↑, FTH1↑, TFR1↓	Improved lung injury and inflammation	124	
Rats with lung epithelial injury	100 mg/kg	MDA↓, Iron↓, SLC7A11↑, GPX4↑, FTH1↑, TFR1↓	
Inflammatory bowel disease	IEC-6 cells	0.125/ 1.25 μM	GSH↑, GPX4↑, MDA↓	Improved mitochondrial morphology	125	
IBD mice	4 mg/kg	Improved typical features of ulcerative colitis, restored the histological structure of the colon, and reduced the destruction of colonic tissue	125	
Periodontitis	Mice with periodontitis	50-200 mg/kg	SOD↓, GSH↑, MDA↓, LC7A11↑, GPX4↑, ACSL4↓, TfR1↓	Reduced periodontal tissue damage	126	
-	MIN6 pancreatic cells	5-20 μM	Iron↓, MDA↓, GSH↑, GPX4↑	Inhibited MIN6 cell death	107	
Osteoarthritis	Mouse chondrocytes	0.5-32 μM	Nrf2↑	Promoted cell proliferation	127	
Knee OA mice	50 mg/kg	Attenuated cartilage degeneration, cartilage erosion and matrix los	
Rat chondrocytes	20-100 μM	GPX4↑	Inhibited apoptosis	128	
Knee OA mice	0.5-1 mg/kg/ body weight	Nrf2↑, HO-1↑	Attenuated articular cartilage degeneration	
Testicular damage	Leydig/sertoli cells	10-30 μM	SP1↑, PRDX6↑	-	129	
Rat with testicular damage	300 mg/kg	Attenuated testicular damage
==== Refs
1 Wu Q Chen Z Ding Y Tang Y Cheng Y Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis Front Nutr 2022 Oct 18 9 1033129 36330148
2 Cao X Wang Y Chen Y Zhao M Liang L Yang M Advances in traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease Journal of Ethnopharmacology 2023 May 307 116229 36773789
3 Xie L Ji X Zhang Q Wei Y Curcumin combined with photodynamic therapy, promising therapies for the treatment of cancer Biomedicine & Pharmacotherapy 2022 Feb 146 112567 34953392
4 Akaberi M, Sahebkar A, Emami SA. Turmeric and Curcumin: From Traditional to Modern Medicine. In: Guest PC, editor. Studies on Biomarkers and New Targets in Aging Research in Iran [Internet]. Cham: Springer International Publishing; 2021 [cited 2023 Aug 23]. p. 15-39. (Advances in Experimental Medicine and Biology; vol. 1291) Available from:https://link.springer.com/10.1007/978-3-030-56153-6_2
5 Peng Y Ao M Dong B Jiang Y Yu L Chen Z Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures DDDT 2021 15 4503 25 34754179
6 Ming T Tao Q Tang S Zhao H Yang H Liu M Curcumin: An epigenetic regulator and its application in cancer Biomedicine & Pharmacotherapy 2022 Dec 156 113956 36411666
7 Zia A Farkhondeh T Pourbagher-Shahri AM Samarghandian S The role of curcumin in aging and senescence: Molecular mechanisms Biomedicine & Pharmacotherapy 2021 Feb 134 111119 33360051
8 Anand P Kunnumakkara AB Newman RA Aggarwal BB Bioavailability of Curcumin: Problems and Promises Mol Pharmaceutics 2007 Dec 1 4 6 807 18
9 Shi Q Shih C Lee K Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity ACAMC 2009 Oct 1 9 8 904 12
10 Heger M Van Golen RF Broekgaarden M Michel MC The Molecular Basis for the Pharmacokinetics and Pharmacodynamics of Curcumin and Its Metabolites in Relation to Cancer. Sibley DR, editor Pharmacol Rev 2014 Jan 66 1 222 307 24368738
11 Burgos-Morón E Calderón-Montaño JM Salvador J Robles A López-Lázaro M The dark side of curcumin Int J Cancer 2010 126 1771 5 19830693
12 Subramaniam D May R Sureban SM Lee KB George R Kuppusamy P Diphenyl Difluoroketone: A Curcumin Derivative with Potent In vivo Anticancer Activity Cancer Research 2008 Mar 15 68 6 1962 9 18339878
13 Cheng AL Hsu CH Lin JK Hsu MM Ho YF Shen TS Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res 2001 21 4B 2895 900 11712783
14 Lao CD Ruffin MT Normolle D Heath DD Murray SI Bailey JM Dose escalation of a curcuminoid formulation BMC Complement Altern Med 2006 Mar 17 6 10 16545122
15 Zhang Y Xia Q Li Y He Z Li Z Guo T CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin Theranostics 2019 Jan 1 9 1 48 64 30662553
16 Zhang Y He Z Li Y Xia Q Li Z Hou X Tumor cell membrane-derived nano-Trojan horses encapsulating phototherapy and chemotherapy are accepted by homologous tumor cells Materials Science and Engineering: C 2021 Jan 120 111670 33545835
17 Joshi P Bisht A Paliwal A Dwivedi J Sharma S Recent updates on clinical developments of curcumin and its derivatives Phytotherapy Research 2023 Aug 3 37 5109 5158 37536946
18 Dixon SJ Lemberg KM Lamprecht MR Skouta R Zaitsev EM Gleason CE Ferroptosis: An Iron-Dependent Form of Non-Apoptotic Cell Death Cell 2012 May 25 149 5 1060 72 22632970
19 Tang D Kang R Berghe TV Vandenabeele P Kroemer G The molecular machinery of regulated cell death Cell Res 2019 May 29 5 347 64 30948788
20 Battaglia AM Chirillo R Aversa I Sacco A Costanzo F Biamonte F Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death Cells 2020 Jun 20 9 6 1505 32575749
21 Wang Y Zhang Z Sun W Zhang J Xu Q Zhou X Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets Biomedicine & Pharmacotherapy 2022 Sep 153 113524 36076606
22 Han C Liu Y Dai R Ismail N Su W Li B Ferroptosis and Its Potential Role in Human Diseases Front Pharmacol 2020 Mar 17 11 239 32256352
23 Green DR Victor B THE PANTHEON OF THE FALLEN Trends Cell Biol 2012 Nov 22 11 555 6 22995729
24 Dixon SJ Ferroptosis: bug or feature? Immunol Rev 2017 May 277 1 150 7 28462529
25 Dan Dunn J Alvarez LA Zhang X Soldati T Reactive oxygen species and mitochondria: A nexus of cellular homeostasis Redox Biol 2015 Sep 10 6 472 85 26432659
26 Paul BT Manz DH Torti FM Torti SV Mitochondria and Iron: Current Questions Expert Rev Hematol 2017 Jan 10 1 65 79 27911100
27 Mou Y Wang J Wu J He D Zhang C Duan C Ferroptosis, a new form of cell death: opportunities and challenges in cancer J Hematol Oncol 2019 Dec 12 1 34 30925886
28 Yu H Guo P Xie X Wang Y Chen G Ferroptosis, a new form of cell death, and its relationships with tumourous diseases J Cell Mol Med 2017 Apr 21 4 648 57 27860262
29 Tang D Kang R From Oxytosis to Ferroptosis: 10 Years of Research on Oxidative Cell Death Antioxidants & Redox Signaling 2023 Jul 1 39 1-3 162 5 37288743
30 Costa I Barbosa DJ Benfeito S Silva V Chavarria D Borges F Molecular mechanisms of ferroptosis and their involvement in brain diseases Pharmacology & Therapeutics 2023 Apr 244 108373 36894028
31 Yin L Liu P Jin Y Ning Z Yang Y Gao H Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications European Journal of Medicinal Chemistry 2022 Dec 244 114861 36332549
32 Xie Y Hou W Song X Yu Y Huang J Sun X Ferroptosis: process and function Cell Death Differ 2016 Mar 23 3 369 79 26794443
33 Lee J Roh JL Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience Cancer Letters 2023 Apr 559 216119 36893895
34 Fearnhead HO Vandenabeele P Vanden Berghe T How do we fit ferroptosis in the family of regulated cell death? Cell Death Differ 2017 Dec 24 12 1991 8 28984871
35 Sun X Ou Z Chen R Niu X Chen D Kang R Activation of the p62-Keap1-NRF2 Pathway Protects against Ferroptosis in Hepatocellular Carcinoma Cells Hepatology 2016 Jan 63 1 173 84 26403645
36 Abdalkader M Lampinen R Kanninen KM Malm TM Liddell JR Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration Front Neurosci 2018 Jul 10 12 466 30042655
37 Zhang X Yu Y Lei H Cai Y Shen J Zhu P The Nrf-2/HO-1 Signaling Axis: A Ray of Hope in Cardiovascular Diseases Cardiol Res Pract 2020 Jan 30 2020 5695723 32411446
38 Forciniti S Greco L Grizzi F Malesci A Laghi L Iron Metabolism in Cancer Progression Int J Mol Sci 2020 Mar 24 21 6 2257 32214052
39 Li K Fan C Chen J Xu X Lu C Shao H Role of oxidative stress-induced ferroptosis in cancer therapy J Cell Mol Med 2024 May 17 28 10 e18399 38757920
40 Lei L Yuan J Yang Q Tu Q Yu H Chu L Curcumin-polydopamine nanoparticles alleviate ferroptosis by iron chelation and inhibition of oxidative stress damage RSC Adv 2024 14 21 14934 41 38716098
41 Liu H He Y Gao X Li T Qiao B Tang L Curcumin alleviates AFB1-induced nephrotoxicity in ducks: regulating mitochondrial oxidative stress, ferritinophagy, and ferroptosis Mycotoxin Res 2023 Nov 39 4 437 51 37782431
42 Valko M Jomova K Rhodes CJ Kuča K Musílek K Redox- and non-redox-metal-induced formation of free radicals and their role in human disease Arch Toxicol 2016 Jan 90 1 1 37 26343967
43 Liang D Minikes AM Jiang X Ferroptosis at the intersection of lipid metabolism and cellular signaling Mol Cell 2022 Jun 16 82 12 2215 27 35390277
44 Andrews NC Disorders of Iron Metabolism The New England Journal of Medicine 1999 341 1968 95
45 Hassannia B Vandenabeele P Vanden Berghe T Targeting Ferroptosis to Iron Out Cancer Cancer Cell 2019 Jun 35 6 830 49 31105042
46 Morales M Xue X Targeting iron metabolism in cancer therapy Theranostics 2021 Jul 25 11 17 8412 29 34373750
47 Wang W Xie Y Malhotra A Potential of Curcumin and Quercetin in Modulation of Premature Mitochondrial Senescence and Related Changes during Lung Carcinogenesis J Environ Pathol Toxicol Oncol 2021 40 4 53 60 34936300
48 Lin H Chen X Zhang C Yang T Deng Z Song Y EF24 induces ferroptosis in osteosarcoma cells through HMOX1 Biomedicine & Pharmacotherapy 2021 Apr 136 111202 33453607
49 Tang X Ding H Liang M Chen X Yan Y Wan N Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy Thorac Cancer 2021 Apr 12 8 1219 30 33656766
50 Cao X Li Y Wang Y Yu T Zhu C Zhang X Curcumin suppresses tumorigenesis by ferroptosis in breast cancer PLoS One 2022 Jan 18 17 1 e0261370 35041678
51 Wu L Xu G Li N Zhu L Shao G Curcumin Analog, HO-3867, Induces Both Apoptosis and Ferroptosis via Multiple Mechanisms in NSCLC Cells with Wild-Type p53 Evid Based Complement Alternat Med 2023 Feb 13 2023 8378581 36814470
52 Yin Y Jiang T Hao Y Zhang J Li W Hao Y Cascade catalytic nanoplatform based on ions interference strategy for calcium overload therapy and ferroptosis International Journal of Pharmaceutics 2021 Sep 606 120937 34310960
53 Zuo S Yu J Pan H Lu L Novel insights on targeting ferroptosis in cancer therapy Biomark Res 2020 Oct 2 8 50 33024562
54 Gao M Monian P Quadri N Ramasamy R Jiang X Glutaminolysis and Transferrin Regulate Ferroptosis Mol Cell 2015 Jul 16 59 2 298 308 26166707
55 Lee J Roh JL Targeting Iron-Sulfur Clusters in Cancer: Opportunities and Challenges for Ferroptosis-Based Therapy Cancers (Basel) 2023 May 10 15 10 2694 37345031
56 Li R Zhang J Zhou Y Gao Q Wang R Fu Y Transcriptome Investigation and In Vitro Verification of Curcumin-Induced HO-1 as a Feature of Ferroptosis in Breast Cancer Cells. Saso L, editor Oxidative Medicine and Cellular Longevity 2020 Nov 19 2020 1 18
57 Xu B Zhu WJ Peng YJ Cheng SD Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the ADAMTS18 gene Transl Cancer Res 2021 Jul 10 7 3158 67 35116623
58 Consoli V Sorrenti V Pittalà V Greish K D'Amico AG Romeo G Heme Oxygenase Modulation Drives Ferroptosis in TNBC Cells Int J Mol Sci 2022 May 20 23 10 5709 35628518
59 Gammella E Recalcati S Rybinska I Buratti P Cairo G Iron-Induced Damage in Cardiomyopathy: Oxidative-Dependent and Independent Mechanisms Oxid Med Cell Longev 2015 2015 230182 25878762
60 Mancias JD Wang X Gygi SP Harper JW Kimmelman AC Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy Nature 2014 May 1 509 7498 105 9 24695223
61 Angeli JPF Schneider M Proneth B Tyurina YY Tyurin VA Hammond VJ Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice Nat Cell Biol 2014 Dec 16 12 1180 91 25402683
62 Chen H Li Z Xu J Zhang N Chen J Wang G Curcumin Induces Ferroptosis in Follicular Thyroid Cancer by Upregulating HO-1 Expression Oxid Med Cell Longev 2023 Jan 14 2023 6896790 36691638
63 Liu Z Ma H Lai Z The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma Molecules 2023 Feb 8 28 4 1623 36838613
64 Kajarabille N Latunde-Dada GO Programmed Cell-Death by Ferroptosis: Antioxidants as Mitigators Int J Mol Sci 2019 Oct 8 20 19 4968 31597407
65 Florean C Song S Dicato M Diederich M Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosis Free Radical Biology and Medicine 2019 Apr 134 177 89 30639617
66 Liu X Cui H Li M Chai Z Wang H Jin X Tumor killing by a dietary curcumin mono-carbonyl analog that works as a selective ROS generator via TrxR inhibition European Journal of Medicinal Chemistry 2023 Mar 250 115191 36758308
67 Zhu J Xiong Y Zhang Y Wen J Cai N Cheng K The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors. Yi X, editor Oxidative Medicine and Cellular Longevity 2020 Dec 21 2020 1 14
68 Stockwell BR Angeli JPF Bayir H Bush AI Conrad M Dixon S Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease Cell 2017 Oct 5 171 2 273 85 28985560
69 Qiu Y Cao Y Cao W Jia Y Lu N The Application of Ferroptosis in Diseases Pharmacological Research 2020 Sep 159 104919 32464324
70 Jia M Qin D Zhao C Chai L Yu Z Wang W Redox homeostasis maintained by GPX4 facilitates STING activation Nat Immunol 2020 Jul 21 7 727 35 32541831
71 Maher P The effects of stress and aging on glutathione metabolism Ageing Research Reviews 2005 May 4 2 288 314 15936251
72 Tang D Chen X Kang R Kroemer G Ferroptosis: molecular mechanisms and health implications Cell Res 2021 Feb 31 2 107 25 33268902
73 Li J Cao F Yin H liang Huang Z jian Lin Z tao Mao N Ferroptosis: past, present and future Cell Death Dis 2020 Feb 3 11 2 88 32015325
74 Yu Y Yan Y Niu F Wang Y Chen X Su G Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases Cell Death Discov 2021 Jul 26 7 193 34312370
75 Barrera G Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy ISRN Oncol 2012 Oct 17 2012 137289 23119185
76 Barrera G Pizzimenti S Dianzani MU Lipid peroxidation: control of cell proliferation, cell differentiation and cell death Molecular Aspects of Medicine 2008 Feb 29 1-2 1 8 18037483
77 Ursini F Maiorino M Lipid peroxidation and ferroptosis: The role of GSH and GPx4 Free Radical Biology and Medicine 2020 May 152 175 85 32165281
78 Chen TC Chuang JY Ko CY Kao TJ Yang PY Yu CH AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis Redox Biol 2019 Dec 26 30 101413 31896509
79 Yuan C Fan R Zhu K Wang Y Xie W Liang Y Curcumin induces ferroptosis and apoptosis in osteosarcoma cells by regulating Nrf2/GPX4 signaling pathway Exp Biol Med (Maywood) 2023 Dec 248 23 2183 97 38166505
80 Liu X Wu Z Guo C Guo H Su Y Chen Q Hypoxia responsive nano-drug delivery system based on angelica polysaccharide for liver cancer therapy Drug Deliv 2022 29 1 138 48 34967268
81 Zhong Y Zhang X Yang L Liang F Zhang J Jiang Y Hierarchical dual-responsive cleavable nanosystem for synergetic photodynamic/photothermal therapy against melanoma Materials Science and Engineering: C 2021 Dec 131 112524 34857303
82 Xu B Zhou L Zhang Q Curcumin Inhibits the Progression of Non-small Cell Lung Cancer by Regulating DMRT3/SLC7A11 Axis Mol Biotechnol 2024
83 Chen M Tan A hui Li J Curcumin Represses Colorectal Cancer Cell Proliferation by Triggering Ferroptosis via PI3K/Akt/mTOR Signaling Nutrition and Cancer 2023 Feb 7 75 2 726 33 36346025
84 Ming T Lei J Peng Y Wang M Liang Y Tang S Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis Phytotherapy Research 2024 Jun 4 38 3954 3972 38837315
85 Scalise M Pochini L Console L Losso MA Indiveri C The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology Front Cell Dev Biol 2018 Sep 4 6 96 30234109
86 Luo M Wu L Zhang K Wang H Zhang T Gutierrez L miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma Cell Death Differ 2018 Aug 25 8 1457 72 29348676
87 Xu T Ding W Ji X Ao X Liu Y Yu W Molecular mechanisms of ferroptosis and its role in cancer therapy J Cell Mol Med 2019 Aug 23 8 4900 12 31232522
88 Doll S Freitas FP Shah R Aldrovandi M Da Silva MC Ingold I FSP1 is a glutathione-independent ferroptosis suppressor Nature 2019 Nov 28 575 7784 693 8 31634899
89 Bersuker K Hendricks J Li Z Magtanong L Ford B Tang PH The CoQ oxidoreductase FSP1 acts in parallel to GPX4 to inhibit ferroptosis Nature 2019 Nov 575 7784 688 92 31634900
90 Zou Y Palte MJ Deik AA Li H Eaton JK Wang W A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis Nat Commun 2019 Apr 8 10 1617 30962421
91 Zhou J Zhang L Yan J Hou A Sui W Sun M Curcumin Induces Ferroptosis in A549 CD133 + Cells through the GSH-GPX4 and FSP1-CoQ10-NAPH Pathways Discovery Medicine 2023 35 176 251 37272092
92 Miyazaki K Xu C Shimada M Goel A Curcumin and Andrographis Exhibit Anti-Tumor Effects in Colorectal Cancer via Activation of Ferroptosis and Dual Suppression of Glutathione Peroxidase-4 and Ferroptosis Suppressor Protein-1 Pharmaceuticals (Basel) 2023 Mar 2 16 3 383 36986483
93 Lu J Holmgren A The thioredoxin antioxidant system Free Radical Biology and Medicine 2014 Jan 66 75 87 23899494
94 Sobotta MC Liou W Stöcker S Talwar D Oehler M Ruppert T Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling Nat Chem Biol 2015 Jan 11 1 64 70 25402766
95 Lu J Holmgren A Thioredoxin System in Cell Death Progression Antioxidants & Redox Signaling 2012 Dec 15 17 12 1738 47 22530689
96 Tonissen KF Di Trapani G Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy Mol Nutr Food Res 2009 Jan 53 1 87 103 18979503
97 Cai W Zhang L Song Y Wang B Zhang B Cui X Small molecule inhibitors of mammalian thioredoxin reductase Free Radical Biology and Medicine 2012 Jan 52 2 257 65 22064364
98 Zhang J Li X Han X Liu R Fang J Targeting the Thioredoxin System for Cancer Therapy Trends in Pharmacological Sciences 2017 Sep 38 9 794 808 28648527
99 Bian M Fan R Zhao S Liu W Targeting the Thioredoxin System as a Strategy for Cancer Therapy: Miniperspective J Med Chem 2019 Aug 22 62 16 7309 21 30963763
100 Xin W Zhang Y Curcumin activates the JNK signaling pathway to promote ferroptosis in colon cancer cells Chem Biol Drug Des 2024 Mar 103 3 e14468 38443754
101 Firouzjaei AA Aghaee-Bakhtiari SH Tafti A Sharifi K Abadi MHJN Rezaei S Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies Cell Biochemistry &amp; Function 2023 Dec 41 8 1488 502 38014635
102 Li G Zhou C Wang L Zheng Y Zhou B Li G MitoCur-1 induces ferroptosis to reverse vemurafenib resistance in melanoma through inhibition of USP14 Pigment Cell Melanoma Res 2024 Mar 37 2 316 28 37985430
103 Friedmann Angeli JP Krysko DV Conrad M Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion Nat Rev Cancer 2019 Jul 19 7 405 14 31101865
104 Chen X Kang R Kroemer G Tang D Broadening horizons: the role of ferroptosis in cancer Nat Rev Clin Oncol 2021 May 18 5 280 96 33514910
105 Li M Tao J Qian R Jiang F Song Y Zeng Z Development of alternative herbals remedy for gastric cancer based on transcriptomic analysis of immune infiltration and ferroptosis Front Genet 2023 Mar 3 14 1086368 36936437
106 Shi M Zhang MJ Yu Y Ou R Wang Y Li H Curcumin derivative NL01 induces ferroptosis in ovarian cancer cells via HCAR1/MCT1 signaling Cellular Signalling 2023 Sep 109 110791 37406786
107 Kose T Vera-Aviles M Sharp PA Latunde-Dada GO Curcumin and (-)- Epigallocatechin-3-Gallate Protect Murine MIN6 Pancreatic Beta-Cells against Iron Toxicity and Erastin-Induced Ferroptosis Pharmaceuticals (Basel) 2019 Feb 6 12 1 26 30736288
108 Wang yan Sun Z Ren X Zhao Z Curcumin inhibits high glucose-induced ferroptosis in Neuro-2a cells via the Nrf2/HO-1 pathway Journal of Fujian Medical University 2023 57 2 79 88
109 Duan C Wang H Jiao D Geng Y Wu Q Yan H Curcumin Restrains Oxidative Stress of After Intracerebral Hemorrhage in Rat by Activating the Nrf2/HO-1 Pathway Front Pharmacol 2022 Apr 27 13 889226 35571134
110 Huang Y Liu J He J Tan F Lu M Yuan F Curcumin preconditioning enhances the neuroprotective effects of olfactory mucosa-derived mesenchymal stem cells on experimental intracerebral hemorrhage Heliyon 2023 Jul 3 9 7 e17874 37483835
111 Yang C Han M Li R Zhou L Zhang Y Duan L Curcumin Nanoparticles Inhibiting Ferroptosis for the Enhanced Treatment of Intracerebral Hemorrhage Int J Nanomedicine 2021 Dec 14 16 8049 65 34938072
112 Hirata Y Ito Y Takashima M Yagyu K Oh-hashi K Suzuki H Novel Oxindole-Curcumin Hybrid Compound for Antioxidative Stress and Neuroprotection ACS Chem Neurosci 2020 Jan 2 11 1 76 85 31799835
113 Ikawa T Sato M Oh-hashi K Furuta K Hirata Y Oxindole-curcumin hybrid compound enhances the transcription of γ-glutamylcysteine ligase European Journal of Pharmacology 2021 Apr 896 173898 33508284
114 Hirata Y Tsunekawa Y Takahashi M Oh-hashi K Kawaguchi K Hayazaki M Identification of novel neuroprotective N,N-dimethylaniline derivatives that prevent oxytosis/ferroptosis and localize to late endosomes and lysosomes Free Radical Biology and Medicine 2021 Oct 174 225 35 34407426
115 Hirata Y Okazaki R Sato M Oh-hashi K Takemori H Furuta K Effect of ferroptosis inhibitors oxindole-curcumin hybrid compound and N,N-dimethylaniline derivatives on rotenone-induced oxidative stress European Journal of Pharmacology 2022 Aug 928 175119 35753403
116 Jiang F Zhang W Lu H Tan M Zeng Z Song Y Prediction of herbal medicines based on immune cell infiltration and immune- and ferroptosis-related gene expression levels to treat valvular atrial fibrillation Front Genet 2022 Sep 28 13 886860 36246656
117 Wei Z Shaohuan Q Pinfang K Chao S Curcumin Attenuates Ferroptosis-Induced Myocardial Injury in Diabetic Cardiomyopathy through the Nrf2 Pathway Cardiovasc Ther 2022 Jul 15 2022 3159717 35909950
118 Kar F Yıldız F Hacioglu C Kar E Donmez DB Senturk H LoxBlock-1 or Curcumin attenuates liver, pancreas and cardiac ferroptosis, oxidative stress and injury in Ischemia/reperfusion-damaged rats by facilitating ACSL/GPx4 signaling Tissue and Cell 2023 Jun 82 102114 37210761
119 Sun X Zhang X Yan H Wu H Cao S Zhao W Protective effect of curcumin on hepatolenticular degeneration through copper excretion and inhibition of ferroptosis Phytomedicine 2023 May 113 154539 36898256
120 Wu L Dong B Chen Q Wang Y Han D Zhu X Effects of Curcumin on Oxidative Stress and Ferroptosis in Acute Ammonia Stress-Induced Liver Injury in Gibel Carp (Carassius gibelio) Int J Mol Sci 2023 Mar 29 24 7 6441 37047414
121 Zhai J Chen Z Zhu Q Guo Z Sun X Jiang L Curcumin inhibits PAT-induced renal ferroptosis via the p62/Keap1/Nrf2 signalling pathway Toxicology 2024 Aug 506 153863 38878878
122 Guerrero-Hue M García-Caballero C Palomino-Antolín A Rubio-Navarro A Vázquez-Carballo C Herencia C Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death FASEB j 2019 Aug 33 8 8961 75 31034781
123 Lou X Lu J Wang C Song Y Zhu L You Y Self-oriented ferritin nanocages mitigate iron overload-induced oxidative stress for acute kidney injury Chemical Engineering Journal 2023 Jun 466 143227
124 Tang X Li Z Yu Z Li J Zhang J Wan N Effect of curcumin on lung epithelial injury and ferroptosis induced by cigarette smoke Hum Exp Toxicol 2021 Dec 40 12_suppl S753 62 34787501
125 Yang J Bai Y Shen S Tao X Ma C Fu B An oral nano-antioxidant for targeted treatment of inflammatory bowel disease by regulating macrophage polarization and inhibiting ferroptosis of intestinal cells Chemical Engineering Journal 2023 Jun 465 142940
126 Wang Y Lin H Huang W Liu Z Chen Z Zhao X Curcumin Attenuates Periodontal Injury via Inhibiting Ferroptosis of Ligature-Induced Periodontitis in Mice Int J Mol Sci 2023 Jun 7 24 12 9835 37372983
127 Zhou Y Jia Z Wang J Huang S Yang S Xiao S Curcumin reverses erastin-induced chondrocyte ferroptosis by upregulating Nrf2 Heliyon 2023 Oct 9 10 e20163 37771529
128 Chen X Chen J Miao C Yin G Zhang Z Sun R Acetyl zingerone ameliorates osteoarthritis by inhibiting chondrocyte programmed cell death Mol Med Rep 2023 Sep 11 28 5 202 37711057
129 Bu H Wang B Wu Y Li P Cui Y Jiang X Curcumin strengthens a spontaneous self-protective mechanism-SP1/PRDX6 pathway, against di-n-butyl phthalate-induced testicular ferroptosis damage Environ Sci Pollut Res 2023 Nov 15 30 58 122165 81
130 An L Li M Jia Q Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma Mol Cancer 2023 Aug 19 22 1 140 37598158
131 Sherman MH Beatty GL Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance Annu Rev Pathol Mech Dis 2023 Jan 24 18 1 123 48
132 Policastro LL Ibañez IL Notcovich C Duran HA Podhajcer OL The Tumor Microenvironment: Characterization, Redox Considerations, and Novel Approaches for Reactive Oxygen Species-Targeted Gene Therapy Antioxidants & Redox Signaling 2013 Sep 10 19 8 854 95 22794113
133 Trachootham D Alexandre J Huang P Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009 Jul 8 7 579 91 19478820
134 Lv H Zhen C Liu J Yang P Hu L Shang P Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy Oxid Med Cell Longev 2019 Jun 10 2019 3150145 31281572
135 Rendra E Riabov V Mossel DM Sevastyanova T Harmsen MC Kzhyshkowska J Reactive oxygen species (ROS) in macrophage activation and function in diabetes Immunobiology 2019 Mar 224 2 242 53 30739804
136 Wu Y Yu C Luo M Cen C Qiu J Zhang S Ferroptosis in Cancer Treatment: Another Way to Rome Front Oncol 2020 Sep 25 10 571127 33102227
137 Torti SV Torti FM Iron and cancer: more ore to be mined Nat Rev Cancer 2013 May 13 5 342 55 23594855
138 W J C A P J L S Novel surface antigen expressed on dividing cells but absent from nondividing cells J Exp Med 1980 Nov 1 152 5 1430 5 6968814
139 Aulbert E Disselhoff W Sörje H Schulz E Gericke D Lysosomal accumulation of 67Ga-transferrin in malignant tumors in relation to their growth rate European Journal of Cancer (1965) 1980 Sep 16 9 1217 32
140 Sutherland R Delia D Schneider C Newman R Kemshead J Greaves M Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin Proc Natl Acad Sci U S A 1981 Jul 78 7 4515 9 6270680
141 Gatter KC Brown G Trowbridge IS Woolston RE Mason DY Transferrin receptors in human tissues: their distribution and possible clinical relevance J Clin Pathol 1983 May 36 5 539 45 6302135
142 Shterman N Kupfer B Moroz C Comparison of Transferrin Receptors, Iron Content and Isoferritin Profile in Normal and Malignant Human Breast Cell Lines Pathobiology 1991 59 1 19 25 2043266
143 Devor EJ Schickling BM Lapierre JR Bender DP Gonzalez-Bosquet J Leslie KK The Synthetic Curcumin Analog HO-3867 Rescues Suppression of PLAC1 Expression in Ovarian Cancer Cells Pharmaceuticals (Basel) 2021 Sep 21 14 9 942 34577642
144 Balogun E Hoque M Gong P Killeen E Green CJ Foresti R Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element Biochem J 2003 May 1 371 Pt 3 887 95 12570874
145 Kim JY Cho TJ Woo BH Choi KU Lee CH Ryu MH Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells Archives of Oral Biology 2012 Aug 57 8 1018 25 22554995
146 Li B Takeda T Tsuiji K Wong TF Tadakawa M Kondo A Curcumin Induces Cross-Regulation Between Autophagy and Apoptosis in Uterine Leiomyosarcoma Cells Int J Gynecol Cancer 2013 Jun 23 5 803 8 23532091
147 Rainey N Motte L Aggarwal BB Petit PX Curcumin hormesis mediates a cross-talk between autophagy and cell death Cell Death Dis 2015 Dec 3 6 12 e2003 e2003 26633709
148 Moustapha A Pérétout P Rainey N Sureau F Geze M Petit JM Curcumin induces crosstalk between autophagy and apoptosis mediated by calcium release from the endoplasmic reticulum, lysosomal destabilization and mitochondrial events Cell Death Discovery 2015 Oct 26 1 1 15017 27551451
149 Guo S Long M Li X Zhu S Zhang M Yang Z Curcumin activates autophagy and attenuates oxidative damage in EA.hy926 cells via the Akt/mTOR pathway Molecular Medicine Reports 2016 Mar 13 3 2187 93 26781771
150 Moghaddam NSA Oskouie MN Butler AE Petit PX Barreto GE Sahebkar A Hormetic effects of curcumin: What is the evidence? Journal Cellular Physiology 2019 Jul 234 7 10060 71
151 Izzo AA Teixeira M Alexander SPH Cirino G Docherty JR George CH A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research Br J Pharmacol 2020 May 177 10 2169 78 32298474
152 Dai E Zhang W Cong D Kang R Wang J Tang D AIFM2 blocks ferroptosis independent of ubiquinol metabolism Biochemical and Biophysical Research Communications 2020 Mar 523 4 966 71 31964528
153 Ou Y Wang SJ Li D Chu B Gu W Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses Proc Natl Acad Sci U S A 2016 Nov 1 113 44 E6806 12 27698118
